State Initiatives

Off-label provisions spread


Twenty-eight states mandate some form of insurance coverage for off-label pharmaceutical use, and the trend is accelerating. In 1997, 11 states implemented off-label coverage provisions. Such laws typically forbid coverage denials based on grounds that an indication has not been approved by the Food and Drug Administration.

SOURCE: STATELINE, SCOTT-LEVIN GOVERNMENT AFFAIRS, NEWTOWN, PA., 1998

Now available

Precision medicine, big data, Alzheimer’s Disease, migraine, and RNA therapeutics.
Learnings from the April 2018 meeting.
Edited by Jill Condello, PhD, ICON Access, Commercialisation & Communications

UP NEXT
Politics and policy
By Richard Mark Kirkner
Politics and policy
By Richard Mark Kirkner
Politics and policy
By Zachary Hafner